Here are the latest quarterly results of LINCOLN PHAR. For more details, see the LINCOLN PHAR financial fact sheet and LINCOLN PHAR share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,026 | 1,235 | 1,406 | 1,338 | 1,125 | 1,356 | 1,560 | 1,464 | |
Other income | Rs m | 19 | 65 | 57 | 64 | 39 | 77 | 87 | 110 | |
Turnover | Rs m | 1,045 | 1,300 | 1,463 | 1,401 | 1,164 | 1,433 | 1,647 | 1,575 | |
Expenses | Rs m | 851 | 1,066 | 1,117 | 1,070 | 958 | 1,149 | 1,248 | 1,168 | |
Gross profit | Rs m | 174 | 169 | 289 | 268 | 166 | 207 | 311 | 297 | |
Depreciation | Rs m | 20 | 21 | 24 | 23 | 24 | 25 | 26 | 28 | |
Interest | Rs m | 6 | 4 | 1 | 3 | 11 | 4 | 4 | 2 | |
Profit before tax | Rs m | 168 | 209 | 321 | 305 | 170 | 254 | 369 | 377 | |
Tax | Rs m | 57 | 59 | 83 | 89 | 44 | 64 | 92 | 97 | |
Profit after tax | Rs m | 110 | 150 | 237 | 216 | 126 | 190 | 277 | 280 | |
Gross profit margin | % | 17.0 | 13.7 | 20.6 | 20.0 | 14.8 | 15.3 | 20.0 | 20.3 | |
Effective tax rate | % | 34.3 | 28.3 | 26.0 | 29.2 | 26.0 | 25.3 | 25.0 | 25.6 | |
Net profit margin | % | 10.7 | 12.2 | 16.9 | 16.2 | 11.2 | 14.0 | 17.7 | 19.1 | |
Diluted EPS | Rs | 5.5 | 7.5 | 11.8 | 10.8 | 6.3 | 9.5 | 13.8 | 14.0 | |
Diluted EPS (TTM) | Rs | 34.6 | 33.3 | 33.6 | 35.6 | 36.4 | 38.4 | 40.4 | 43.6 | |
Subscriber Feature |
After opening the day on negative note, Indian benchmark indices slipped further as the session progressed and ended Thursday on Weak note.